Cellvio Biomedical LLC has the knowledge, experience, staff and facility to produce different cell populations and their products at a scale and quality necessary for therapeutics to patients with debilitating oncological, neurodegenerative and cardiovascular conditions. This includes Type I diabetes, heart damage, spinal cord injury, multiple sclerosis, Parkinson, Alzheimer’s, stroke, retinal diseases and different kinds of skin diseases.

Stem cell technology-based therapy (adult stem cells) has the potential to transform healthcare industry over the next several years. There is clear evidence from published literature that the rapidly growing cell therapy sector is the next big frontier of the biotech/pharmaceutical industry. Clinical application require that the number of cells be significantly expanded to the level of billions in order to commercialize the delivery of medical needs. It is well known that the conventional culture methods are not practical which makes scalable manufacturing processes very challenging. The combination of our stem cell biology experience and our scalable bioreactor makes us an ideal service provider company in the cell therapy industry. We work closely with client companies to provide them with workable solutions in order to reduce the economic risks that could occur during the development process.